The Development of Human Papillomavirus (HPV) Vaccines and Current Barriers to Implementation

References

• American College of Obstetricians and Gynecologists. 2016. Practice bulletin no. 157: cervical cancer screening and prevention. Obstet Gynecol. 127(1):e1–20. doi:10.1097/AOG.0000000000001263.
   PubMedGoogle Scholar
• Arbyn M, Xu L, Simoens C, Martin-Hirsch PP. 2018. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev. 5(5):CD009069.
   PubMedGoogle Scholar
• Asiaf A, Ahmad ST, Mohammad SO, Zargar MA. 2014. Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection. Eur J Cancer Prev. 23(3):206–24.
   PubMed Web of Science ®Google Scholar
• Bansal N, Wright JD, Cohen CJ, Herzog TJ. 2008. Natural history of established low grade cervical intraepithelial (CIN 1) lesions. Anticancer Res. 28(3B):1763–66.
   PubMed Web of Science ®Google Scholar
• Bednarczyk RA. 2019. Addressing HPV vaccine myths: practical information for healthcare providers. Hum Vaccin Immunother. 15(7–8):1628–38.
   PubMed Web of Science ®Google Scholar
• Blitz S, Baxter J, Raboud J, Walmsley S, Rachlis A, Smaill F, Ferenczy A, Coutlee F, Hankins C, Money D. 2013. Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women. J Infect Dis. 208(3):454–62.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). 2013. Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013 – United States. MMWR Morb Mortal Wkly Rep. 62(29):591–95.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). 2015. Epidemiology and prevention of vaccine-preventable diseases. 13th ed. Hamborsky J, Kroger A, Wolfe S, editors. Washington, DC: Public Health Foundation.
   Google Scholar
• Chabeda A, Yanez RJR, Lamprecht R, Meyers AE, Rybicki EP, Hitzeroth II. 2018. Therapeutic vaccines for high-risk HPV-associated diseases. Papillomavirus Res. 5:46–58.
   PubMed Web of Science ®Google Scholar
• Coles VA, Patel AS, Allen FL, Keeping ST, Carroll SM. 2015. The association of human papillomavirus vaccination with sexual behaviors and human papillomavirus knowledge: a systemic review. Int J STD AIDS. 26(11):777–88.
   PubMed Web of Science ®Google Scholar
• Crabtree BF, Miller WL, Aita VA, Flocke SA, Strange KC. 1998. Primary care practice organization and preventive services delivery: a qualitative analysis. J Fam Pract. 46(5):403–09.
   PubMed Web of Science ®Google Scholar
• Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW Jr, Kemper AR, Kubik M, et al. 2018. Screening for cervical cancer: US preventive services task force recommendation statement. JAMA. 320(7):674–86. doi:10.1001/jama.2018.10897.
   PubMed Web of Science ®Google Scholar
• Davies P, Chapman S, Leask J. 2002. Antivaccination activists on the world wide web. Arch Dis Child. 87(1):22–25.
   PubMed Web of Science ®Google Scholar
• De Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, et al. 2010. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 11(11):1048–56. doi:10.1016/S1470-2045(10)70230-8.
   PubMed Web of Science ®Google Scholar
• Drolet M, Benard E, Perez N, Brisson M, Ali H, Boily M-C, Baldo V, Brassard P, Brotherton JML, Callander D. 2019. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programs: updated systemic review and meta-analysis. Lancet. 394(10197):497–509. HPV Vaccination Impact Study Group. doi:10.1016/S0140-6736(19)30298-3.
   PubMed Web of Science ®Google Scholar
• Dudley MZ, Salmon DA, Halsey NA, Orenstein WA, Limaye RJ, O’Leary ST, Moer SB. 2018. The clinician’s vaccine safety resource guide: optimizing prevention of vaccine-preventable diseases across the lifespan. Cham, Switzerland: Springer International Publishing.
   Google Scholar
• Ferris D, Samakoses R, Block SL, Lazcano-Ponce E, Restrepo JA, Reisinger KS, Mehlsen J, Chatterjee A, Iversen OE, Sings HL, et al. 2014. Long-term study of a quadrivalent human papillomavirus vaccine. Pediatrics. 134(3):e657–65. doi:10.1542/peds.2013-4144.
   PubMed Web of Science ®Google Scholar
• Fontham ETH, Wolf AMD, Church TR, Etzioni R, Flowers CR, Herzig A, Guerra CE, Oeffinger KC, Shih YT, Walter LC, et al. 2020. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA: A Cancer J Clin. 70(5):321–46. doi:10.3322/caac.21628.
   PubMed Web of Science ®Google Scholar
• Frisch M, Glimelius B, Van Den Brule AJ, Wohlfahrt J, Meijer CJ, Walboomers JM, Goldman S, Svensson C, Adami HO, Melbye M. 1997. Sexually transmitted infection as a cause of anal cancer. N Engl J Med. 337(19):1350–58.
   PubMed Web of Science ®Google Scholar
• Gibb RK, Martens MG. 2011. The impact of liquid-based cytology in decreasing the incidence of cervical cancer. Rev Obstet Gynecol. 4(Suppl 1):S2–S11.
   PubMedGoogle Scholar
• Hopfer S, Wright ME, Pellman H, Wasserman R, Fiks AG. 2019. HPV vaccine recommendation profiles among a national network of pediatric practitioners: understanding contributors to parental vaccine hesitancy and acceptance. Hum Vaccin Immunother. 15(7–8):1776–83.
   PubMed Web of Science ®Google Scholar
• Houlihan CF, Larke NL, Watson-Jones D, Smith-mccune KK, Shiboski S, Gravitt PE, Smith JS, Kuhn L, Wang C, Hayes R. 2012. Human papillomavirus infection and increased risk of HIV acquisition. A systemic review and meta-analysis. AIDS. 26(17):2211–22.
   PubMed Web of Science ®Google Scholar
• Joura EA, Giuliano AR, Iverson OE, Bouchard C, Mao C, Mehlsen J, Moreira ED Jr, Ngan Y, Petersen LK, Lazcano-Ponce E, et al. 2015. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med. 372(8):711–23. doi:10.1056/NEJMoa1405044.
   PubMed Web of Science ®Google Scholar
• Kahn JA, Lan D, Kahn RS. 2007. Sociodemographic factors associated with high-risk human papillomavirus infection. Obstet Gynecol. 110(1):87–95.
   PubMed Web of Science ®Google Scholar
• Kjaer SK, Nygard M, Sundstrom K, Dillner J, Tryggvadottir L, Munk C, Berger S, Enerly E, Hortlund M, Agustsson A, et al. 2020. Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four Nordic countries. EClin Med. 23:100401.
   PubMedGoogle Scholar
• Knipe DM, Levy O, Fitzgerald KA, Muhlberger E. 2020. Ensuring vaccine safety. Science. 370(6522):1274–75.
   PubMed Web of Science ®Google Scholar
• Lau M, Lin H, Flores G. 2012. Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 National Survey of Children’s Health. Vaccine. 30(20):3112–18.
   PubMed Web of Science ®Google Scholar
• Lechuga J. 2012. Need for effective HPV vaccine promotional messaging before sexual activity begins. Ethn Dis. 22(3):266.
   PubMed Web of Science ®Google Scholar
• Lei J, Ploner A, Elfstrom KM, Wang J, Roth A, Fang F, Sundstrom K, Dillner J, Sparen P. 2020. HPV vaccination and the risk of invasive cervical cancer. N Engl J Med. 383(14):1340–48.
   PubMed Web of Science ®Google Scholar
• Maglennon GA, Doorbar J. 2012. The biology of papillomavirus latency. Open Virol J. 6:190–97.
   PubMedGoogle Scholar
• Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, Bocchini JA Jr, Unger ER. 2014. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 63(RR–05):1–30. Centers for Disease Control and Prevention (CDC).
   PubMed Web of Science ®Google Scholar
• Matys K, Mallary S, Bautista O, Vuocolo S, Manalastas R, Pitisuttithum P, Saah A. 2012. Mother-infant transfer of anti-human papillomavirus (HPV) antibodies following vaccination with the quadrivalent HPV (type 6/11/16/18) virus-like particle vaccine. Clin Vaccine Immunol. 19(6):881–85.
   PubMedGoogle Scholar
• McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, Skegg DC. 2008. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 9(5):425–34.
   PubMed Web of Science ®Google Scholar
• McDougall JA, Madeleine MM, Daling JR, Li C. 2007. Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992-2003. Cancer Causes Control. 18(10):1175–86.
   PubMed Web of Science ®Google Scholar
• Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. 2019. Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 68(32):698–702.
   PubMed Web of Science ®Google Scholar
• Nayar R, Wilbur DC. 2015. The pap test and bethesda 2014. Cancer Cytopathol. 123(5):271–81.
   PubMed Web of Science ®Google Scholar
• Neha R, Subeesh V, Beulah E, Gouri N, Maheswari E. 2020. Postlicensure surveillance of human papillomavirus vaccine using the Vaccine Adverse Event Reporting System, 2006-2017. Perspect Clin Res. 11(1):24–30.
   PubMedGoogle Scholar
• Perkins RB, Clark JA, Apte G, Vercruysse JL, Sumner JJ, Wall-Haas CL, Rosenquist AW, Pierre-Joseph N. 2014. Missed opportunities for HPV vaccination in adolescent girls: a qualitative study. Pediatrics. 134(3):e666–74.
   PubMed Web of Science ®Google Scholar
• Petaja T, Keranen H, Karppa T, Kawa A, Lantela S, Siitari-Mattila M, Levanen H, Tocklin T, Godeaux O, Lehtinen M, et al. 2009. Immunogenicity and safety of human papillomavirus (HPV) – 16/18 AS04-adjuvanted vaccine in healthy boys aged 10-18 years. Adolesc Health. 44(1):33–40. doi:10.1016/j.jadohealth.2008.10.002.
   PubMed Web of Science ®Google Scholar
• Rambout L, Tashkandi M, Hopkins L, Tricco AC. 2014. Self-reported barriers and facilitators to preventative human papillomavirus vaccination among adolescent girls and young women: a systemic review. Prev Med. 58:22–32.
   PubMed Web of Science ®Google Scholar
• Rosenthal SL, Rupp R, Zimet GD, Meza HM, Loza ML, Short MB, Succop PA. 2008. Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health. 43(3):239–45.
   PubMed Web of Science ®Google Scholar
• Sawaya GF, Kulasingam S, Denberg TD, Qaseem A. 2015. Cervical cancer screening in average-risk women: best practice advice from the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med. 162(12):851–59. Clinical Guidelines Committee of American College of Physicians. doi:10.7326/M14-2426.
   PubMed Web of Science ®Google Scholar
• Schiller J, Markowitz L, Hildesheim A, Lowy D. 2018. Human papillomavirus vaccines. In: Plotkin S, Orenstein W, Offit P, Edwards K. editors. Plotkin’s vaccines. Philadelphia, PA: Seventh. Elsevier. p. 430–55.
   Google Scholar
• Shay LA, Baldwin AS, Betts AC, Marks EG, Higashi RT, Street RL Jr, Persaud D, Tiro JA. 2018. Parent-provider communication of HPV vaccine hesitancy. Pediatrics. 141(6):e20172312.
   PubMed Web of Science ®Google Scholar
• Sinal SH, Woods CR. 2005. Human papillomavirus infections of the genital and respiratory tracts in young children. Semin Pediatr Infect Dis. 16(4):306–16.
   PubMedGoogle Scholar
• Stanley M. 2006. Immune responses to human papillomavirus. Vaccine. 24(Suppl 1):S16–22.
   PubMed Web of Science ®Google Scholar
• Stelzle D, Tanaka LF, Lee KK, Ibrahim Khalil A, Baussano I, Shah ASV, McAllister DA, Gottlieb SL, Klug SJ, Winkler AS, et al. 2020. Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 9(2):e161–69. doi:10.1016/S2214-109X(20)30459-9.
   PubMed Web of Science ®Google Scholar
• Stokley S, Jeyarajah J, Yankey D, Cano M, Gee J, Roark J, Curtis RC, Markowitz L. 2014. Human papillomavirus vaccination coverage among adolescents, 2007-2013, and post-licensure vaccine safety monitoring, 2006-2014 – United States. MMWR Morb Mortal Wkly Rep. 63(29):620–24. Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC.
   PubMed Web of Science ®Google Scholar
• Toh ZQ, Russell FM, Reyburn R, Fong J, Tuivaga E, Ratu T, Nguyen CD, Devi R, Kama M, Matanitobua S, et al. 2017. Sustained antibody responses 6 years following 1, 2, or 3 doses of quadrivalent human papillomavirus (HPV) Vaccine in adolescent Fijian girls, and subsequent responses to single dose of bivalent HPV vaccine: a prospective cohort study. Clin Infect Dis. 64(7):852–59. doi:10.1093/cid/ciw865.
   PubMed Web of Science ®Google Scholar
• Van Dyne EA, Henley SJ, Saraiya M, Thomas CC, Markowitz LE, Benard VB. 2018. Trends in human papillomavirus-associated cancers – united States, 1999-2015. MMWR Morb Mortal Wkly Rep. 67(33):918–24.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Brodszki N, Van Damme P, Diez-Domingo J, Icardi G, Petersen LK, Tran C, Thomas S, Luxembourg A, Baudin M. 2015. A randomized, double-blind, Phase 3 study of the immunogenicity and safety of a 9-valent human papillomavirus L1 virus-like particle vaccine versus Gardasil in 9-15-year-old girls. Pediatr Infect Dis J. 34(9):992–98.
   PubMed Web of Science ®Google Scholar
• Wakabayashi R, Nakahama Y, Nguyen V, Espinoza JL. 2019. The host-microbe interplay in human papillomavirus-induced carcinogenesis. Microorganisms. 7(7):199.
   Web of Science ®Google Scholar
• Walker TY, Elam-Evans LD, Yankey D, Markowitz LE, Williams CL, Fredua B, Singleton JA, Stokley S. 2019. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years – United States, 2018. MMWR Morb Mortal Wkly Rep. 68(33):718–23.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2011. The immunological basis for immunization series: module 19: human papillomavirus. Geneva, Switzerland: World Health Organization Press.
   Google Scholar
• Zimet GD, Mays RM, Sturm LA, Ravert AA, Perkins SM, Juliar BE. 2005. Parental attitudes about sexually transmitted infection vaccination for their adolescent children. Arch Pediatr Adolesc Med. 159(2):132–37.
   PubMed Web of Science ®Google Scholar